Editor/NN
's/POS
Introduction/NN
to/TO
This/DT
Issue/NN
(/(
G/NN
&/CC
I/NN
15:1/CD
,/,
2017/CD
)/)
./.
====================
Clinical/JJ
sequencing/NN
has/VBZ
become/VBN
a/DT
part/NN
of/IN
medical/JJ
practice/NN
./.
====================
It/PRP
is/VBZ
widely/RB
accepted/VBN
that/IN
clinical/JJ
sequencing/NN
is/VBZ
the/DT
main/JJ
tool/NN
of/IN
precision/NN
medicine/NN
and/CC
can/MD
facilitate/VB
the/DT
selection/NN
of/IN
the/DT
right/JJ
drug/NN
at/IN
right/JJ
dose/NN
to/TO
the/DT
right/JJ
patient/NN
at/IN
the/DT
right/JJ
time/NN
./.
====================
To/TO
reflect/VB
the/DT
importance/NN
of/IN
clinical/JJ
sequencing/NN
,/,
in/IN
this/DT
issue/NN
,/,
Genomics/NNS
&/CC
Informatics/NNS
opens/NNS
a/DT
new/JJ
section/NN
,/,
termed/VBN
‘/NN
Clinical/JJ
Genomics/NNS
’/CD
./.
====================
Genomics/NNS
&/CC
Informatics/NNS
would/MD
like/IN
to/TO
encourage/VB
medical/JJ
scientists/NNS
to/TO
submit/VB
any/DT
type/NN
of/IN
clinical/JJ
sequencing/NN
data/NNS
if/IN
they/PRP
have/VBP
potential/JJ
implications/NNS
in/IN
medical/JJ
practice/NN
or/CC
provide/VBP
biological/JJ
insights/NNS
./.
====================
The/DT
first/JJ
paper/NN
in/IN
the/DT
Clinical/JJ
Genomics/NNS
section/NN
is/VBZ
on/IN
the/DT
successful/JJ
detection/NN
of/IN
somatic/JJ
mutations/NNS
from/IN
circulating/VBG
plasma/NN
DNA/NN
of/IN
a/DT
breast/NN
cancer/NN
patient/NN
./.
====================
Dr./NNP
Seung-Hyun/NN
Jung/NN
's/POS
group/NN
(/(
The/DT
Catholic/JJ
University/JJ
of/IN
Korea/NN
,/,
College/NNP
of/IN
Medicine/NN
,/,
Korea/NN
)/)
examined/VBD
the/DT
mutation/NN
profile/NN
of/IN
primary/JJ
tumor/NN
tissue/NN
from/IN
a/DT
breast/NN
cancer/NN
patient/NN
using/VBG
a/DT
cancer/NN
panel/NN
that/IN
they/PRP
developed/VBD
and/CC
identified/VBD
several/JJ
somatic/JJ
point/NN
mutations/NNS
and/CC
copy/NN
number/NN
alterations/NNS
./.
====================
They/PRP
examined/VBN
whether/IN
the/DT
alterations/NNS
identified/VBD
from/IN
tumor/NN
tissue/NN
were/VBD
consistently/RB
detected/VBN
in/IN
plasma/NN
DNA/NN
isolated/VBN
from/IN
the/DT
same/JJ
patient/NN
and/CC
confirmed/VBD
that/IN
both/CC
point/NN
mutations/NNS
and/CC
copy/NN
number/NN
alterations/NNS
were/VBD
consistently/RB
identified/VBN
in/IN
two/CD
sources/NNS
./.
====================
There/EX
are/VBP
five/CD
original/JJ
articles/NNS
in/IN
this/DT
issue/NN
./.
====================
Dr./NNP
Jong-Keuk/NN
Lee/NNP
's/POS
group/NN
(/(
Ulsan/NNP
University/NN
,/,
Korea/NN
)/)
evaluated/VBD
digital/JJ
PCR/NN
as/IN
a/DT
system/NN
for/IN
monitoring/VBG
graft/NN
status/NN
using/VBG
SNP-based/JJ
detection/NN
of/IN
donor/NN
DNA/NN
in/IN
plasma/NN
or/CC
urine/NN
./.
====================
They/PRP
found/VBD
that/IN
donor/NN
DNA/NN
was/VBD
almost/RB
undetectable/JJ
in/IN
plasma/NN
DNA/NN
samples/NNS
,/,
whereas/IN
a/DT
high/JJ
percentage/NN
of/IN
donor/NN
DNA/NN
was/VBD
detected/VBN
in/IN
urine/NN
DNA/NN
samples/NNS
./.
====================
Therefore/RB
,/,
they/PRP
suggested/VBD
that/IN
urine/NN
is/VBZ
a/DT
good/JJ
source/NN
of/IN
cfDNA/JJ
for/IN
monitoring/VBG
acute/JJ
rejection/NN
in/IN
patients/NNS
after/IN
kidney/NN
transplantation/NN
./.
====================
Dr./NNP
Seon-Young/NN
Kim/NN
's/POS
group/NN
(/(
KRIBB/NN
,/,
Korea/NN
)/)
developed/VBD
a/DT
new/JJ
ChIP-seq/NN
data/NNS
analysis/NN
pipeline/NN
,/,
based/VBN
on/IN
Bioconductor/NN
packages/NNS
./.
====================
They/PRP
also/RB
developed/VBD
a/DT
graph-based/JJ
database/NN
and/CC
reported/VBD
its/PRP$
feasibility/NN
./.
====================
In/IN
the/DT
application/NN
note/RB
section/NN
,/,
Dr./NNP
Ju/NNP
Han/JJ
Kim/NN
's/POS
group/NN
(/(
Seoul/JJ
National/JJ
University/NN
,/,
Korea/NN
)/)
proposed/VBN
an/DT
R-based/JJ
RNA-seq/NN
analysis/NN
pipeline/NN
called/VBN
TRAPR/NN
,/,
which/WDT
is/VBZ
an/DT
integrated/JJ
tool/NN
that/IN
facilitates/VBZ
the/DT
statistical/JJ
analysis/NN
and/CC
visualization/NN
of/IN
RNA-seq/JJ
expression/NN
data/NNS
./.
====================
For/IN
further/RBR
details/VBZ
,/,
please/NN
visit/FW
the/DT
G/NN
&/CC
I/NN
homepage/NN
(/(
http/NN
:/:
//www.kogo.or.kr/webapp/kogo_publish/genomics_and_informatics//JJ
)/)
./.
====================
